¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

´ëÇѽÉÀåÇÐȸ 2019³â ºÎ»ê,¿ï»ê,°æ³²½ÉÀåÇÐȸ Ãá°è¿¬¼ö°­Á : 2019-04-06

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
´ëÇѽÉÀåÇÐȸ 2019³â ºÎ»ê,¿ï»ê,°æ³²½ÉÀåÇÐȸ Ãá°è¿¬¼ö°­Á : 2019-04-06
±³À°ÀÏÀÚ : 2019-04-06
±³À°Àå¼Ò : ºÎ»ê ÇØ¿î´ë º¤½ºÄÚ  
±³À°ÁÖÁ¦ : 2019³â ºÎ»ê,¿ï»ê,°æ³²½ÉÀåÇÐȸ Ãá°è¿¬¼ö°­ÁÂ
ÁÖÃÖ±â°ü : ´ëÇѽÉÀåÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : ºÎ¿ï°æÁöȸ  
´ã´çÀÚ : Á¶º°
¿¬¶ôó : 051-890-8676  
À̸ÞÀÏ : cvcenter@hanmail.net      
±³À°Á¾·ù : ³»°úÀÇ»çÇÐ, ÀÇ·áÄ¿¹Â´ÏÄÉÀ̼Ç, ÀÇÇб³À°, ±âŸ
Âü¼®¿¹»óÀοø : 200¸í
Èñ¸ÁÆòÁ¡ : 6Á¡  
Áö¿ª : ºÎ»ê±¤¿ª½Ã
±³À°½Ã°£ : 7 ½Ã°£ 0ºÐ  
¼¼ºÎ¼ö°­·á : 0¿ø      
ºñ°í       

±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 04-06 º¤½ºÄÚ 09:00~09:15 What¡¯s New and What¡¯s Not in updated hypertension guideline  ¹Ú°æÀÏ(µ¿¾ÆÀÇ´ë) 
±³À°½Ã°£ 04-06 º¤½ºÄÚ 09:15~09:30 What¡¯s New and What¡¯s Not in 2018 ACC/AHA cholesterol guideline  ¼Û¿©Á¤(ÀÎÁ¦ÀÇ´ë) 
±³À°½Ã°£ 04-06 º¤½ºÄÚ 09:30~09:45 How do I treat HT/Dyslipidemia as an experienced cardiologist  ½ÅÀº¼®(¿ï»êº´¿ø) 
Åä·Ð 04-06 º¤½ºÄÚ 09:45~10:00 discussion  ´Ù°­»ç(´Ù¼Ò¼Ó) 
±³À°½Ã°£ 04-06 º¤½ºÄÚ 10:00~10:15 Antithrombotic therapy in patient who developed AF after PCI  ±Ç¿ë¼·(¼º¸ðº´¿ø) 
±³À°½Ã°£ 04-06 º¤½ºÄÚ 10:15~10:30 Recent update in image & physiology guided PCI  ¾È¼­Èñ(¿ï»êÀÇ´ë) 
±³À°½Ã°£ 04-06 º¤½ºÄÚ 10:30~10:45 When should we consider revascularization of CTOs?  Àü±¹Áø(ºÎ»êÀÇ´ë) 
Åä·Ð 04-06 º¤½ºÄÚ 10:45~11:00 discussion  ´Ù°­»ç(´Ù¼Ò¼Ó) 
±³À°½Ã°£ 04-06 º¤½ºÄÚ 11:00~12:00 Coffee break & Moderated poster session  ´Ù°­»ç(´Ù¼Ò¼Ó) 
±³À°½Ã°£ 04-06 º¤½ºÄÚ 12:00~12:15 Anticoagulation strategy after successful sinus conversion of AF  ±è±âÈÆ(ÀÎÁ¦ÀÇ´ë) 
±³À°½Ã°£ 04-06 º¤½ºÄÚ 12:15~12:30 When Should AF Patients with CHA2DS2-VASc  °­±¸Çö(°æÈñÁß¾Óº´¿ø) 
±³À°½Ã°£ 04-06 º¤½ºÄÚ 12:30~12:45 Practical approach to syncope  È²±â¿ø(ºÎ»êÀÇ´ë) 
Åä·Ð 04-06 º¤½ºÄÚ 12:45~13:00 discussion  ´Ù°­»ç(´Ù¼Ò¼Ó) 
½Ä»ç 04-06 º¤½ºÄÚ 13:00~14:00 Luncheon session - entresto  ÀÎÁ¦ÀÇ´ë(±è´ë°æ) 
±³À°½Ã°£ 04-06 º¤½ºÄÚ 14:00~14:15 Should we consider surgical closure of ASD even with severe pulmonary HT?  ±èºÀÁØ(°í½ÅÀÇ´ë) 
±³À°½Ã°£ 04-06 º¤½ºÄÚ 14:15~14:30 New definition of PAH and its clinical implication  ÃÖÁ¤Çö(ºÎ»êÀÇ´ë) 
±³À°½Ã°£ 04-06 º¤½ºÄÚ 14:30~14:45 Treatment of intractable pericardial effusion  ÀåÁ¤À±(°æ»óÀÇ´ë) 
Åä·Ð 04-06 º¤½ºÄÚ 14:45~15:00 discussion  ´Ù°­»ç(´Ù¼Ò¼Ó) 
È޽Ġ04-06 º¤½ºÄÚ 15:00~15:20 Coffee break  () 
±³À°½Ã°£ 04-06 º¤½ºÄÚ 15:20~15:35 Appropiate selection of TAVR in patients with AS  ¾çÅÂÇö(ÀÎÁ¦ÀÇ´ë) 
±³À°½Ã°£ 04-06 º¤½ºÄÚ 15:35~15:50 Update in femoro-popliteal intervention  ±è¼öÈ«(º¸Èƺ´¿ø) 
±³À°½Ã°£ 04-06 º¤½ºÄÚ 15:50~16:05 New device in endovascular repair of aortic aneurysm  Ãµ¹Î±¸(ºÎ»êÀÇ´ë) 
Åä·Ð 04-06 º¤½ºÄÚ 16:05~16:20 discussion  ´Ù°­»ç(´Ù¼Ò¼Ó) 
±³À°½Ã°£ 04-06 º¤½ºÄÚ 16:20~16:35 Diagnosis and treatment of cardiac sarcoidosis  ÀÌ»óÇö(ºÎ»êÀÇ´ë) 
±³À°½Ã°£ 04-06 º¤½ºÄÚ 16:35~16:50 Echocardiographic evaluation of LVAD  ¹ÚÁ¤¶û(°æ»óÀÇ´ë) 
±³À°½Ã°£ 04-06 º¤½ºÄÚ 16:50~17:05 Management of end-stage HF  ¼³»óÈÆ(ÀÎÁ¦ÀÇ´ë) 
Åä·Ð 04-06 º¤½ºÄÚ 17:05~17:20 discussion  ´Ù°­»ç(´Ù¼Ò¼Ó) 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" ´ëÇѽÉÀåÇÐȸ 2019³â ºÎ»ê,¿ï»ê,°æ³²½ÉÀåÇÐȸ Ãá°è¿¬¼ö°­Á : 2019-04-06""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û ¿µ³²´ëº´¿ø Á¦46ȸ ´ëÇÑ°©»ó¼±µÎ°æºÎ¿Ü°úÇÐȸ Áõ·ÊÇмú´ëȸ : 2019-04-06
´ÙÀ½±Û ¼­¿ï¾Æ»êº´¿ø 2019³â ´ëÇѼ¼Æ÷º´¸®ÇÐȸ Á¦33Â÷ º½ Çмú´ëȸ : 2019-04-06
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20895 ¼­¿ï ´ëÇѼҾƽÅÀåÇÐȸ (¿Â¶óÀÎ) 2024³â ¼Ò¾Æ½ÅÀå Post-graduate education course : 2024-07-01 0 3 2024-05-28
20894 ´ëÀü Ãæ³²´ëÇб³º´¿ø 2024³â °³¿øÀÇ¿Í ÇÔ²²ÇÏ´Â ³»°ú ¿¬¼ö°­Á : 2024-06-30 0 3 2024-05-28
20893 ¼­¿ï ´ëÇѳúÁ¹ÁßÇÐȸ 6¿ù º¸¼ö±³À° : 2024-06-30 0 107 2024-05-27
20892 ¼­¿ï (¿Â¶óÀÎ)Á¦22Â÷ ¼­¿ïƯº°½ÃÀÇ»çȸ Çмú´ëȸ : 2024-06-30 0 9 2024-05-27
20891 °æ±â (¿Â¶óÀÎ)Á¦21Â÷ °æ±âµµÀÇ»çȸ ¿Â¶óÀÎ Çмú´ëȸ : 2024-06-30 0 23 2024-05-27
20890 Àü³² 2024³â ´ëÇÑ´ëÀåÇ×¹®ÇÐȸ ¿¬¼ö°­Á : 2024-06-30 0 10 2024-05-27
20889 Ãæ³² ´ëÇÑÁ¤Çü¿Ü°úÃÊÀ½ÆÄÇÐȸ - Á¦19Â÷ Ãá°èÇмú´ëȸ ¹× Á¦38Â÷ ±Ù°ñ°Ý°è ÃÊÀ½ÆÄ¿öÅ©¼¥ (Basic Course) : 2024-06-30 0 5 2024-05-27
20888 ºÎ»ê Á¦3ȸ ´ëÇÑÅõ¼®Çùȸ ºÎ»êÁöȸ ½ÉÆ÷Áö¾ö : 2024-06-29 0 4 2024-05-27
20887 ¼­¿ï Çѱ¹ÁöÁú¤ýµ¿¸Æ°æÈ­ÇÐȸ Á¦7ȸ A to Z (Atherosclerosis to Zero) ¿¬¼ö°­Á ÇÁ·Î±×·¥ : 2024-06-29 0 1 2024-05-27
20886 °æ±â 2024³âµµ ³²¾çÁÖ½ÃÀÇ»çȸ Çмú´ëȸ : 2024-06-29 0 1 2024-05-27
20885 ¼­¿ï (¿Â¶óÀÎ)Á¦14ȸ ´ëÇÑ°¨¿°ÇÐȸ Æò»ý±³À° ÇÁ·Î±×·¥ °¨¿°Áúȯ ÃÖ½ÅÁö°ß : 2024-06-29 0 5 2024-05-27
20884 ¼­¿ï Á¦24Â÷ ´ëÇѽÅÀåÇÐȸ ½ÅÀ̽Ŀ¬±¸È¸ ¿¬¼ö°­Á : 2024-06-29 0 1 2024-05-27
20883 ¼­¿ï 2024 ¼±Ãµ¼º Ⱦ°æ¸· Å»Àå ÄÚȣƮ (K-CDH) ±³À°¼¼¹Ì³ª : 2024-06-29 0 9 2024-05-27
20882 ¼­¿ï 2024 ¿©¼º½ÉÀåÁúȯ¿¬±¸È¸ ÇÏ°è ½ÉÆ÷Áö¾ö : 2024-06-29 0 1 2024-05-27
20881 °­¿ø 2024 ³âµµ Á¤Çü¿Ü°úÇб³½Ç °³¿øÀÇ¿¬¼ö°­Á : 2024-06-29 0 6 2024-05-27
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷